New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 24, 2018 - AbbVie announced the FDA approval of Orilissa (elagolix), for the management of moderate to severe pain associated with endometriosis.
Download PDF
Return to publications
